UBS lowered the firm’s price target on Veeva (VEEV) to $280 from $310 and keeps a Neutral rating on the shares. The firm updated its model following the quarterly earnings report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Veeva price target lowered to $280 from $300 at Canaccord
- Strong Financial Performance and Growth Prospects Make Veeva Systems a Compelling Investment Opportunity
- Veeva Systems: Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Cautious Outlook on Veeva Systems Amidst CRM Market Challenges and Competitive Pressures
- Veeva Systems: Strong Q3 Performance, But Hold Rating Due to Limited Upside and CRM Uncertainty
